- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04240574
Debritom - Micro Water Jet Technology and Wound Healing
March 1, 2023 updated by: Stephanie Wu
Evaluation of Micro Water Jet Technology and the Progression of Wound Healing: A Prospective Cohort Evaluating the Efficacy of Micro Water Jet Technology in the Debridement and Healing of Chronic Lower Extremity Ulcers
This study will investigate the clinical efficacy of micro water jet technology in the debridement and healing of chronic lower extremity ulcers.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This is a prospective cohort, single-center, open-label study in subjects with chronic lower extremity wounds.
The study will enroll up to 20 subjects.
Subjects will undergo screening evaluations to determine eligibility to enroll in the study.
All study subjects will receive micro water jet technology debridement as opposed to other debridement methods as part of their wound care treatment.
The other aspects of subjects wound care protocol will remain unchanged.
In the case of bilateral limb ulcers, or multiple ulcers, subjects will have the option to receive micro water jet debridement on one or all of the ulcers.
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
North Chicago, Illinois, United States, 60064
- Rosalind Franklin University Health Clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female age 18 or older
- The ability and willingness to provide Informed consent
- Presence of a chronic lower extremity ulcer
- Chronic ulcer is defined as that greater than 4 weeks in duration.
- Subject's informed consent for participation prior to proceeding with micro water jet technology debridement
- Patient's ulcer cannot exhibit any gross clinical signs of infection.
- Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.
- Patient willing and able to comply with having micro water jet technology debridement potentially weekly or biweekly as part of their wound care treatment plan for up to 20 weeks.
Exclusion Criteria:
- Patients with active wound infection, or untreated osteomyelitis
- Patients with dementia, or impaired cognitive function
- Patients who are unable or unwilling to participate in all procedures and follow up evaluations
- Patient has Active Charcot foot
- Patient with malignant wounds
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Micro Water Jet Technology (Debritom)
Debritom is a hydrosurgery device that utilizes micro water jet technology that has been designed to debride acute and chronic wounds precisely and in a tissue-preserving manner. All subject will get the Debritom. |
hydrosurgery device that utilizes micro water jet technology that has been designed to debride acute and chronic wounds precisely and in a tissue-preserving manner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Size of Ulcers
Time Frame: Up to 20 weeks or when the ulcer is healed, whichever is sooner.
|
The extent and size of ulcers (summation of the products of the long x short axis for all ulcers measured in centimeters squared, plus ulcer depth) will be evaluated and photographs of ulcers taken during screening and on all clinic visits up to 20 weeks or when the ulcer is healed, whichever is sooner.
|
Up to 20 weeks or when the ulcer is healed, whichever is sooner.
|
|
Leg Rest Pain Score
Time Frame: up to 20 weeks, or when the ulcer is healed, whichever is sooner
|
Leg rest pain score - visual analogue scale (VAS) graded from 0 (pain free) to Grade 10 (maximum pain) during screening and on all clinic visits up to 20 weeks, or when the ulcer is healed, whichever is sooner.
|
up to 20 weeks, or when the ulcer is healed, whichever is sooner
|
|
Pain During Debridement Score
Time Frame: up to 20 weeks, sooner pending wound healing.
|
Pain during Debridement score - VAS graded from 0 (pain free) to Grade 10 (maximum pain) during on all clinical visits when debridement is performed for up to 20 weeks, sooner pending wound healing.
|
up to 20 weeks, sooner pending wound healing.
|
|
Subjects Feedback
Time Frame: At end of their study participation
|
Subjects feedback regarding their debridement experience with micro water jet technology will be collected on all clinical visits when debridement is performed.
|
At end of their study participation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2020
Primary Completion (Actual)
August 6, 2021
Study Completion (Actual)
August 6, 2021
Study Registration Dates
First Submitted
January 6, 2020
First Submitted That Met QC Criteria
January 21, 2020
First Posted (Actual)
January 27, 2020
Study Record Updates
Last Update Posted (Actual)
March 27, 2023
Last Update Submitted That Met QC Criteria
March 1, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Skin Diseases
- Endocrine System Diseases
- Diabetic Angiopathies
- Skin Ulcer
- Diabetes Complications
- Diabetes Mellitus
- Diabetic Neuropathies
- Foot Diseases
- Varicose Veins
- Diabetic Foot
- Foot Ulcer
- Ulcer
- Wounds and Injuries
- Leg Ulcer
- Varicose Ulcer
Other Study ID Numbers
- MDX-DEB-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Will not share
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot Ulcer
-
DEBx Medical B.V.Not yet recruitingDiabetic Foot Wounds | Diabetic Foot Ulcer (DFU) | Diabetic Foot Ulcer Treatment
-
StimLabsNot yet recruitingDiabetic Foot | Foot Ulcer | Ulcer Foot | Diabetic Foot Ulcer (DFU)
-
Applied Biologics, LLCSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Diabetic Foot Ulcers (DFU) | Foot Ulcer ChronicUnited States
-
PolarityTETemporarily not availableNeuropathic Diabetic Ulcer - Foot | Diabetic Foot Disease | DFU
-
Cairo UniversityNot yet recruitingDiabetic Foot UlcerEgypt
-
Omeza, LLCSygNola, LLCRecruitingDiabetic Foot UlcerUnited States
-
Universidad Autonoma de Nuevo LeonCompleted
-
Applied Biologics, LLCSerenaGroup, Inc.RecruitingDiabetic Foot | Foot Ulcer | Diabetic Foot Ulcer | Ulcer Foot | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | DFUUnited States
-
Libyan Center for Biotechnology ResearchNot yet recruiting
-
Başakşehir Çam & Sakura City HospitalRecruitingDiabetic Foot Infection | Diabetic Amputation Foot Wound | Diabetic Foot DiseaseTurkey (Türkiye)
Clinical Trials on Debritom
-
School of Health Sciences GenevaCompletedWound Heal | Chronic WoundSwitzerland
-
Medaxis, LLCProfessional Education and Research InstituteActive, not recruitingDiabetic Foot | Diabetic Foot UlcerUnited States